Supplementary Tables1 from Clinical Significance of EGFR Amplification in Patients with EGFR-Mutated Metastatic Non–Small Cell Lung Cancer Receiving First-line Osimertinib
Year: 2026
Type: supplementary-materials
Abstract: Supplementary Tables.
Authors: Alessandro Di Federico, Federica Pecci, Mark Jeng, Marianna Peroni, Daniele Marinelli, Alessandro Leonetti, Sara Stumpo, Francesco Mantuano, Irene Zannini, Eleonora Gariazzo, Maisam Makarem, Amanda Pupo, Francesca Lo Bianco, Andrea De Giglio, Dario de Biase, Annalisa Altimari, Elisa Gruppioni, Roberta Minari, Michela Verzè, Matteo Repetto, Francesca Sperandi, Barbara Melotti, Francesco Gelsomino, Lorenza Landi, Maristella Giammaruco, Stefano Scalera, Laura Cipriani, Marcello Maugeri-Saccà, Nicola Calonaci, Giulio Caravagna, Biagio Ricciuti, Lynette M. Sholl, Soo Ryum Yang, Jaclyn LoPiccolo, Julia K. Rotow, Mark M. Awad, Federico Cappuzzo, Marcello Tiseo, Helena A. Yu, Pasi A. Jänne, Andrea Ardizzoni
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7213349651
Cites:
Cited by:
Related to: